Rational phenytoin therapy: a method for individualizing dosage
Wu, J.Z.
Zhonghua Yi Xue Za Zhi 66(3): 134-136; 188
1986
ISSN/ISBN: 0376-2491 PMID: 3094864 Document Number: 268680
Document emailed within 1 workday
Related Documents
Yukawa, E.; Higuchi, S.; Aoyama, T. 1991: One-point feedback control method for phenytoin dosage adjustment Journal of Pharmacy and Pharmacology 43(7): 499-503Sharfstein, J.; Agrawal, D.; Jeffrey, P. 1998: Phenytoin dosage Pediatrics 102(5): 1223
Cordonnier, J.; Hache, J.; Storey, M. 1987: Phenytoin dosage with the use of a personal computer Journal de Pharmacie de Belgique 42(2): 128-134
Plavsić, F.; Francetić, I. 1981: Pharmacokinetics in individualizing therapy Srpski Arhiv Za Celokupno Lekarstvo 109(3): 391-402
Turja, J.; Grothey, A. 2008: Individualizing therapy for metastatic colorectal cancer Oncology 22(13): 1479-1481
Calne, D.B.; Duvoisin, R.C.; Koller, W.C. 1994: Individualizing therapy in patients with disabling Parkinson's disease symptoms Neurology 44(3 Suppl 1: S8-11
Edmonds, D.; Huss, R.; Jeck, T.; Mengden, T.; Schubert, M.; Vetter, W. 1990: Individualizing antihypertensive therapy with enalapril versus atenolol: the Zurich experience Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 8(4): S49-S52
Branzi, A.; Rapezzi, C. 1988: Beta-blockade therapy in heart failure. Rational bases of the interpretation of clinical data and clinical evidence in search of rational interpretation Giornale Italiano di Cardiologia 18(10): 843-846
Dudkiewicz-Wilczyńska, J.; Snycerski, A.; Tautt, J. 2000: HPLC method for the determination of oxytocin in pharmaceutical dosage form and comparison with biological method Acta Poloniae Pharmaceutica 57(6): 403-406
Jefferys, R.J. 2005: Lower phenytoin serum levels in persons switched from brand to generic phenytoin Neurology 65(4): 657-8; Author Reply 657-8
Wierzchowiecki, M.; Swiderczuk, A.; Dyderski, S.; Masiakowski, J.; Jazienicki, B. 1987: Studies of the biological availability of phenytoin preparations (Polfa) and micronized phenytoin in patients with cardiac rhythm disorders Kardiologia Polska 30(9): 577-582
Sharov, B.K. 1973: Selection of a rational method of pneumomediastinography Voprosy Onkologii 19(3): 27-32
Strauss, R.G.; Ramsay, R.E.; Willmore, L.J.; Wilder, B.J. 1978: Hematologic effects of phenytoin therapy during pregnancy Obstetrics and Gynecology 51(6): 682-685
Bukaev, N.B. 1989: Rational method for determining the optimum layer in tomograms of the lungs Problemy Tuberkuleza 3: 57-60
Blaha, L.; Zenglein, R.; Wiedmayer, J. 1979: Therapy of acute schizophrenic attacks. High dosage haloperidol therapy compared with a two component treatment Fortschritte der Medizin 97(23): 1095-1100
Schön, F. 1981: Rational time-saving method of construction for cast post crowns Zwr 90(4): 44
Mamedov, A.G. 1988: Rational variant of the method of freeing the finger from the hard-to-remove ring Vestnik Khirurgii Imeni I. I. Grekova 141(10): 112-114
Overduin, L.M. 1992: Clinical trial on sustained-release phenytoin. Preliminary results of the open, non-controlled study. the Phenytoin Trial Group on Canine Epilepsy Tijdschrift Voor Diergeneeskunde 117(Suppl 1): 27s-28s
Reisner, R.M. 1976: The rational therapy of acne Cutis 17(3): 527-530
Smith, K.A. 1997: Rational interleukin-2 therapy Cancer Journal from Scientific American 3(Suppl 1): S137-S140